Federal Circuit: Claim Amendments During IPR That Respond to Grounds of Unpatentability May Also Make Changes Unrelated to the IPR

Dec 1, 2022

Reading Time : 1 min

In American National Manufacturing, Inc. v. Sleep Number Corp, the appellant-petitioner American National argued that the PTAB erred in its application of 37 C.F.R. § 42.121 when it permitted Sleep Number to include certain claim amendments to “achieve consistency and accuracy in terminology and phrasing throughout the patent family.” Section 42.121 specifies that a motion to amend may be denied where “[t]he amendment does not respond to a ground of unpatentability involved in the trial.” In applying this regulation, the PTAB determined that any claim amended to address a ground of unpatentability could also be amended for other reasons, including potential § 101 and § 112 issues.

On appeal, American National argued the Board violated due process and the APA by allowing additional amendments in the context of an IPR. More specifically, American National argued it would be unfair and asymmetrical to allow patentees to use an IPR as a vehicle to amend claims to address § 101 or § 112 issues when petitioners cannot challenge claims on those grounds.

The Federal Circuit, however, disagreed. Citing previous decisions, the court noted that petitioners are free to challenge amended claims on grounds that go beyond § 102 and § 103, including on § 101 and § 112. Thus, it discerned no asymmetry between patentees and petitioners in the context of a motion to amend. And because each of the amended claims contained an amendment responsive to a ground of unpatentability raised in the IPR proceeding, Sleep Number’s additional amendments were not improper.

Practice Tip: For patentees facing co-pending litigation and IPR proceedings, there may be an opportunity to amend claims to defeat both the IPR petition and live defenses in the litigation. It is important, however, to weigh that value of such a result against the risk of possible invalidation or intervening rights. And, similarly, defendants considering filing an IPR petition must weigh the possibility that the Patent Owner might use a motion to amend to remedy potential § 112 deficiencies.

American National Manufacturing, Inc. v. Sleep Number Corporation, Case Nos. 2021-1321

Share This Insight

Previous Entries

IP Newsflash

December 18, 2025

The Federal Circuit recently vacated a $20 million jury verdict in favor of a patentee and remanded with instructions to dismiss the case for lack of subject matter jurisdiction, finding that the patentee did not own the asserted patents at the time it filed suit and therefore lacked standing.

...

Read More

IP Newsflash

December 17, 2025

The Federal Circuit recently affirmed a Patent Trial and Appeal Board decision finding claims that had been subject to an ex parte reexamination unpatentable. As a threshold issue, the court held that IPR estoppel under 35 USC § 315(e)(1) does not apply to ongoing ex parte reexaminations. Accordingly, the Patent Office did not err in continuing the reexamination after issuing final written decisions in co-pending IPRs.

...

Read More

IP Newsflash

December 15, 2025

The District of Delaware recently denied a defendant’s motion to dismiss plaintiff’s demand for enhanced damages based on willful infringement pursuant to 35 U.S.C. § 284, explaining that neither a demand for damages under § 284 nor an accusation of willful infringement amount to a claim for relief that can be subject to dismissal under Rule 12(b)(6).

...

Read More

IP Newsflash

December 9, 2025

The Federal Circuit recently denied a petition for a writ of mandamus that challenged the PTO Director’s reliance on “settled expectations” to discretionarily deny two inter partes review (IPR) petitions. In so doing, the court explained that, while it was not deciding whether the Director’s use of “settled expectations” was correct, the petitioner’s arguments about what factors the Director may consider when deciding whether to institute an IPR or post-grant review (PGR) are not generally reviewable and did not provide sufficient basis for mandamus review here.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.